Related Experiment Video
Updated: Apr 17, 2026

11:47
A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
Published on: June 8, 2014
12.2K
Impact of targeted PPARγ disruption on bone remodeling
Jay Cao1, Guomin Ou2, Nianlan Yang2
1USDA ARS Grand Forks Human Nutrition Research Center, Grand Forks, ND, United States.
Molecular and Cellular Endocrinology
|February 11, 2015
Summary
Peroxisome proliferator-activated receptor gamma (PPARγ) deletion in bone cells increases osteoblasts, aiding bone repair. This study clarifies PPARγ’s role in bone remodeling, not skeletal development.
Area of Science:
- Bone Biology
- Stem Cell Biology
- Endocrinology
Background:
- Peroxisome proliferator-activated receptor gamma (PPARγ) regulates adipogenesis and is a potential therapeutic target for osteoporosis.
- The exact role of PPARγ in bone regulation is unclear due to confounding effects from other tissues.
- A bone-specific PPARγ conditional knockout (cKO) model is needed to elucidate its precise function in bone.
Purpose of the Study:
- To investigate the specific role of PPARγ in bone biology using a bone-specific cKO mouse model.
- To determine the effect of PPARγ deletion on bone marrow mesenchymal stem/progenitor cell (BMSC) lineage commitment.
- To clarify the mechanism by which PPARγ influences bone remodeling and skeletal development.
Main Methods:
- Generated bone-specific PPARγ cKO mice (PPAR(fl/fl):Col3.6-Cre).
- Performed in vitro studies on primary bone marrow cultures and isolated BMSCs.
- Conducted histology and histomorphometry analyses on cKO mice.
- Assessed osteoclast differentiation and function.
Main Results:
- PPARγ cKO mice exhibited a moderate, site-dependent decrease in bone mass.
- In vitro, adipogenesis was abolished, and osteoblastogenesis was significantly increased in PPARγ-deficient cells.
- Histomorphometry revealed increased osteoblast numbers and surface in cKO mice.
- Osteoclast differentiation and function remained unaffected.
Conclusions:
- PPARγ plays a crucial role in bone remodeling by promoting osteoblast abundance for repair.
- PPARγ is not essential for skeletal development.
- Targeting PPARγ may offer a therapeutic strategy for bone repair in conditions like osteoporosis.
More Related Videos
Related Concept Videos
Bone Remodeling
41.3K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
41.3K
Osteoclasts in Bone Remodeling
4.9K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
4.9K
Hormones and Bone Tissue
4.3K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
4.3K
Bone Disorders
8.8K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
8.8K
TGF - β Signaling Pathway
11.1K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
11.1K

